Contact Us | Sitemap
logo
About ISTA Products Pipeline Careers Investors

Image
ISTA Investor Information


BROMDAY™

(bromfenac ophthalmic solution) 0.09%
 

BEPREVE
BEPREVE®

(bepotastine besilate
ophthalmic solution) 1.5%
 

Istalol
Istalol®

(timolol maleate
ophthalmic solution) 0.5%
 

Investor Highlights

Presentations
Stock Quotes
Quarterly Fact sheet

Products

BROMDAY

BEPREVE

Istalol

Vitrase
 

Press Releases

  • ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan
  • ISTA's Board of Directors to Review Valeant's Revised Proposal as Part of Its Ongoing Review of Strategic Options
  • ISTA Pharmaceuticals Announces U.S. Patent Allowance for PROLENSA(TM) in the United States
Top | Contact Us | Products | MSDS | Disclaimer | Sitemap | Educational Grant Requests

© 2012 ISTA Pharmaceuticals, Inc.